Literature DB >> 8891447

Adaptation of a simple flow cytometric assay to identify different stages during apoptosis.

W Hamel1, P Dazin, M A Israel.   

Abstract

Apoptosis occurs under many different physiological and pathological conditions, and it reflects a genetically encoded suicide program that can be triggered by different stimuli in susceptible cells. We adapted a flow cytometric assay for the detection of apoptosis based on differential staining of viable cells with two different DNA binding dyes, propidium iodide (PI) and Hoechst 33342 (Ho342). Apoptosis was induced in different cell lines by gamma irradiation, an anti-FAS monoclonal antibody, or ganciclovir in Herpes simplex virus-thymidine kinase-expressing cells. We could identify three different populations that appeared sequentially after the induction of apoptosis. Cells corresponding to these populations were sorted and assessed for evidence of apoptosis as determined by alterations of nuclear morphology and detection of endonucleolytic activity. This analysis revealed a PI- population with subtle apoptotic changes and increased Ho342 fluorescence compared with untreated cells. Extensive apoptotic alterations were observed in a PI+ population that increased over time following the induction of apoptosis. A third population was characterized by an intermediate intensity of PI fluorescence and decreased Ho342 fluorescence compared with the other populations. This population appeared late after treatment and consisted of apoptotic bodies. Taken together, these data suggest that distinct stages of apoptosis can be identified by differential staining of cells with Ho342 and PI. This assay should be useful for the detection and further characterization of cells at different stages in the apoptotic process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891447     DOI: 10.1002/(SICI)1097-0320(19961001)25:2<173::AID-CYTO6>3.0.CO;2-I

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  7 in total

1.  Measurement of cell death in mammalian cells.

Authors:  Brian S Cummings; Rick G Schnellmann
Journal:  Curr Protoc Pharmacol       Date:  2004-09-01

Review 2.  Apoptosis: clinical relevance and pharmacological manipulation.

Authors:  U Thatte; S Dahanukar
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

3.  Development of an ischemic tolerance model in a PC12 cell line.

Authors:  Joëlle A Hillion; Kenzo Takahashi; Dragan Maric; Christl Ruetzler; Jeffery L Barker; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2005-02       Impact factor: 6.200

4.  Semaphorin 6A regulates angiogenesis by modulating VEGF signaling.

Authors:  Marta Segarra; Hidetaka Ohnuki; Dragan Maric; Ombretta Salvucci; Xu Hou; Anil Kumar; Xuri Li; Giovanna Tosato
Journal:  Blood       Date:  2012-09-24       Impact factor: 22.113

5.  Involvement of Akt in preconditioning-induced tolerance to ischemia in PC12 cells.

Authors:  Joëlle A Hillion; YiXin Li; Dragan Maric; Asako Takanohashi; Dace Klimanis; Jeffrey L Barker; John M Hallenbeck
Journal:  J Cereb Blood Flow Metab       Date:  2006-03-01       Impact factor: 6.200

6.  Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis.

Authors:  D Ilić; E A Almeida; D D Schlaepfer; P Dazin; S Aizawa; C H Damsky
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

Review 7.  Current concepts in apoptosis: the physiological suicide program revisited.

Authors:  Indrajit Chowdhury; Binu Tharakan; Ganapathy K Bhat
Journal:  Cell Mol Biol Lett       Date:  2006-09-05       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.